123 results
Page 2 of 7
8-K
EX-99.2
vnly266
18 Jul 22
Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow
9:28pm
PRE 14A
cp3bi
4 Apr 22
Preliminary proxy
4:15pm
424B5
8iiptw
2 Mar 22
Prospectus supplement for primary offering
8:24am
S-3ASR
52bwor4 kcq5
2 Mar 22
Automatic shelf registration
6:06am
8-K
EX-99.2
2uyqperv6y zb0aw
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
8-K
EX-99.1
o9cq in21qwbbax9g3u
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
8-K
EX-1.1
f4oec
4 May 21
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
k6kc2a eaea6oocp9d
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm
8-K/A
EX-99.4
gmgn0zkxwylejr
5 Apr 21
Financial Statements and Exhibits
4:11pm
8-K
EX-99.1
7rwp3ufr2zbd39qohk
17 Feb 21
Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020
4:09pm
8-K
EX-1.1
89tpd hjoxf11lycw
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
stfk70y cgl71fh8
25 Jan 21
Prospectus supplement for primary offering
4:02pm